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Abstract
Background: Chronic musculoskeletal pain is the single most cited reason for use of complementary and
alternative medicine (CAM). Primary care is the most frequent conventional medical service used by
patients with pain in the UK. We are unaware, however, of a direct evidence of the extent of CAM use
by primary care patients, and how successful they perceive it to be.
Methods: 
Aims and objectives: To determine CAM use among patients with chronic musculoskeletal pain who
have consulted about their pain in primary care.
Study design: Face-to-face interview-based survey.
Setting: Three general practices in North Staffordshire.
Participants: Respondents to a population pain survey who had reported having  musculoskeletal pain
in the survey and who had consulted about their pain  in primary care in the previous 12 months as well
as consenting to further  research and agreeing to an interview. Information was gathered about  their pain
and the use of all treatments for pain, including CAM, in the  previous year.
Results: 138 interviews were completed. 116 participants (84%) had used at  least one CAM treatment
for pain in the previous year. 65% were current  users of CAM. The ratio of over-the-counter CAM use
to care from a CAM  provider was 3:2. 111 participants (80%) had used conventional treatment.  95 (69%)
were using a combination of CAM and conventional treatment.  Glucosamine and fish oil were the most
commonly used CAM treatments (38%,  35% respectively). Most CAM treatments were scored on average
as being  helpful, and users indicated that they intended to use again 87% of the  CAM treatments they had
already used.  
Conclusion: We provide direct evidence that most primary care consulters with  chronic
musculoskeletal pain have used CAM in the previous year, usually  in combination with conventional
treatments. The high prevalence and wide  range of users experiences of benefit and harm from CAM
strengthen the  argument for more research into this type of medicine to quantify benefit  and assess
safety. The observation that most users of conventional  medicine also used CAM suggests a continuing
need for more investigation  of effective pain management in primary care.
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Surveys have suggested that use of complementary and
alternative medicines (CAM) is high and increasing
worldwide [1]. Longitudinal studies in the UK between
1993 [2] and 1999 [3], 1995 [4] and 2001 [5] and
between 1998 [6] and 2006 [7] and in the USA between
1990 [8] and 1997 [9] have confirmed the trend. CAM is
most commonly used for chronic pain and in particular
musculoskeletal pain [7] and is often used in combina-
tion with conventional therapies [10]. GPs are the con-
ventional medical practitioners most frequently consulted
for chronic pain in the UK [11].
A number of surveys have been conducted in the UK to
explore CAM use. Some of these were general population
surveys [2,3,11-13], surveys among patients with defini-
tive rheumatologic diagnoses attending hospital clinics
[14-18], or surveys of healthcare professionals exploring
their patients' use of CAM and access to it [19-
21,4,5,22,23].
In primary care in the UK, surveys targeted healthcare pro-
fessionals rather than patients. [4,5] We are not aware of
surveys conducted in the UK that have directly explored
CAM use among primary care patients who suffer from
chronic musculoskeletal pain. Evidence suggests that
users do not necessarily access CAM through primary care
and also they are often reluctant to inform their doctors of
their use of these treatments [9,24]. Figures on access to
CAM through primary care and on health professionals'
provision of CAM, therefore, might have under-repre-
sented actual CAM use among primary care patients.
We are not aware of previous surveys of primary care
patients that have enquired about the perceived helpful-
ness of treatments from the patients' perspectives. This is
important for understanding healthcare seeking behav-
iour among chronic pain sufferers, for informing effective
pain management in primary care and because of poten-
tial safety issues related to CAM use.
We wanted to address these issues with particular focus on
musculoskeletal pain sufferers who are using primary care
in the UK. We have therefore investigated the pattern of
CAM use in a sample of chronic musculoskeletal pain
patients who were consulting primary care in the UK. Our
hypothesis was that this group of patients would have a
higher prevalence of CAM use than general population
samples or pain sufferers generally. This was based on the
idea that this group will have selectively more severe prob-
lems than the general population because they have
sought health care and because chronic musculoskeletal
pain is often unresponsive to conventional primary care
treatments
Methods
Setting and study population
The population consisted of adults, aged 18 years and
older, registered with three general practices in the North
Staffordshire General Practice Research Network.
The sample was drawn from responders to previous postal
health surveys [25,26] conducted in the Network. They
had agreed to further contact and to use of their medical
records for specific research purposes. Approval for this
specific study was obtained from the North Staffordshire
Ethics Committee. We first identified all patients who had
reported pain in the surveys and who had consulted their
general practitioners during a defined 12-month period
with any condition or syndrome of chronic musculoskel-
etal pain as identified from their computerised medical
records. The quality of the coded consultation data in the
Network practices is audited regularly and this has been
reported previously in the literature [27]. The main inclu-
sion criterion was a record of a consultation for muscu-
loskeletal pain during the 12 months prior to the
interview. We excluded patients with pain caused by or
associated with malignancy (primary or secondary), vis-
ceral (gynaecological or general surgical), vascular, neuro-
pathic conditions or infections. We also excluded
individuals who were known by their GPs to have
impaired cognitive function. Language was not an exclud-
ing criterion. GPs reviewed the final list to further exclude
patients on the basis of terminal illness or inappropriate-
ness for social reasons.
Sample size
Anticipating the prevalence of CAM use on the basis of
previous surveys to be at least 30%-50%, we calculated
that 180 patients would need to be recruited in order to
detect at least 20% difference in prevalence between dif-
ferent socio-demographic groups with 80% power. Given
the need for an in-depth interview, we predicted a
response rate of 40–50%. The total number of potential
participants identified was 427. We invited all of them to
participate in order to generate our calculated sample size.
Design
The methods used were a combination of a face-to-face
structured interview, a self-completed questionnaire and
data collection from medical records. The interview ques-
tionnaire consisted of three sections. Section A was about
the timing of pain and its location. Section B was about
treatments used for pain control and consisted of eight
questions. Section C included questions about socio-
demographic characteristics. For social and occupational
classifications we used the Office for National Statistics
socio-economic classification (NS – SEC) [28].Page 2 of 14
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used for pain. A list of treatment names was not used at
this stage and it was clearly explained to participants that
we wanted to know of anything they had used or anything
done to help them with their pain. After answers were
obtained to that question, a list of treatments was then
introduced (Table 1) and participants were asked to
answer the same question, again, this time with the aid of
the list. The list included all types of treatments (conven-
tional and items of self-care as well as CAM) which could
be used for pain, regardless of type, classification, defini-
tion, local availability, prevalence of use or effectiveness.
Boxplot summary of perceived helpfulness scores on the VAS for the most commonly used CAM treatmentsFigure 1
Boxplot summary of perceived helpfulness scores on the VAS for the most commonly used CAM treatments. Values repre-
sented are number of users and 5-number summary (median, 25th and 75th percentiles and range) and outlier observations 
(data that lie outside the interval: median ± 1.5× mid-spread).Page 3 of 14
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follows about each of the treatments used, with partici-
pants being asked to choose from lists of responses.
We asked whether practitioners had been involved in the
treatment; answers classified to 'no', 'yes throughout' or
'yes at some stage only'. Participants were also asked
detailed questions, where applicable, about how they
were introduced to the treatment; reasons for using it, and
reasons for stopping it. Participants were also asked how
helpful they had found the treatment, scored on a
numeric visual analogue scale (VAS) ranging from (+10)
'very helpful' to (-10) 'very harmful', with zero defining
'not helpful and not harmful'. Current use of a treatment
was defined as 'use during the week leading to the inter-
view'. Those who had stopped a treatment were asked
about the reasons for stopping. Finally participants were
asked about their intention for future use of each current
or previously used treatment. In the list of options for
each answer, there was an 'other' option which allowed
participants to freely state his or her answer if different
from the listed ones.
At the end of the interview the Chronic Pain Grade (CPG)
questionnaire [29] was self-completed by participants.
This seven item self-complete instrument provides a score
of severity, enabling chronic pain patients to be classified
into one of four categories which combine persistence
(duration), intensity and disability:- Grade I, low disabil-
ity-low intensity; Grade II, low disability-high intensity;
Grade III, high disability-moderately limiting; and Grade
IV, high disability-severely limiting. Its use has been vali-
dated in the USA and the UK [30].
All interviews were conducted between April and July
2004 by one researcher (MA). The format was piloted
with five patients from a general practice outside the
study. 10 random interviews from the main study were
videoed and studied by an independent qualitative
researcher at our Centre, applying criteria for quality
developed by De Vaus [31].
CAM and conventional treatments
Our identification of treatments as 'CAM' and 'conven-
tional' was based on our literature review, and on the
views of 26 clinical and non-clinical researchers in our
Centre, whose main topic of research is musculoskeletal
pain. We surveyed the latter about how they would clas-
sify the list of treatments used in our main survey.
Although this was not a formal Delphi procedure, the aim
Table 1: A list of treatments addressed in the study.
Treatments included in interview list
CAM Conventional Additional CAM treatments reported by participants
1.Aromatherapy 26.Muscle energy techniques 1.Ultrasound 1.Exercises
2.Homeopathy 27.Therapeutic touch 2.Vitamins 2.Heat therapy
3.Magnets 28.Alexander Technique 3.Joint injections 3.Heat cream
4.Copper bracelets 29.Massage Therapy 4.Occupational Therapy 4.Biocomfort
5.Evening primrose 30.Phytodolor 5.Operations 5.Dog oil
6.Reflexology 31.Osteopathic manipulation 6.Podiatry 6.Glyco-nutrient
7.Naturopathy 32.Electrotherapy 7.Psychotherapy 7.Honey & vinegar
8.Feverfew extract 33.Chondroitin sulphate 8.Aspirin 8.Cold pack
9.Blackcurrant seed oil 34.Glucosamin 9.Celecoxib 9.Geranium & eucalyptus
10.Ayurvedic herbs 35.Lifestyle program 10.Co-codamol 10.Reiki
11.Borage seed oil 36.Minerals 11.Co-codaprin 11.Swimming
12.Devil's claw 37. Weight loss program 12.Co-dydramol 12.Dowsing
13.Ginger 38.Active release technique 13.Co-proxamol 13.Electrical massage
14.Thunder God Root 39.Myofascial release 14.Diclofenac sodium 14.Florid acid
15.Acupuncture 40.Soft tissue mobilization 15.Ibuprofen 15.Lavender oil
16.Acupressure 41.Biofeedback 16.Indomethacin 16.Singapore balm
17.Tumaric 42.Guided imagery 17.Mefenamic acid
18.Hypnosis 43.Pilates 18.Meloxicam
19.Energy Healing 44.Prayer 19.Naproxen
20.Fish oil 45.Relaxation 20.Nefopam
21.Willow bark extract 46.Tai Chi 21.Paracetamol
22.Meditation 47.Yoga 22.Piroxicam
23.Pet Therapy 48.Hydrotherapy 23.Rofecoxib
24.Chiropractic 49.Chelation
25.Craniosacral Therapy 50.Serums
51.VaccinesPage 4 of 14
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current ideas about whether an individual therapy is more
or less 'CAM'. 51 treatments were classified as 'CAM' and
23 as conventional (Table 1).
One of the difficulties facing research in the field of CAM
is defining this type of 'medicine'. It is a heterogeneous
group of therapies, substances, supplements, procedures,
techniques, rituals, practices, systems etc, which people
use, do and undergo while seeking to alleviate health
problems or to maintain health. Because of their great
diversity, the only way to identify these treatments as a
distinct group seems to have been by 'negatively' defining
them as treatments that are not taught in medical schools
or provided in hospitals. In 1982, this group of treatments
was defined as "treatments that a conventional unit is unlikely
to prescribe" [14]. Within that were included aids for the
home (used by patients with arthritis) as well as herbs and
acupuncture. Other researchers defined CAM as a "name
given to a system of healthcare that lies predominantly outside
the mainstream of conventional medicine" [15].
Ernst [24] defined this type of medicine as "diagnosis, treat-
ment and/or prevention which complements mainstream med-
icine by contributing to a common whole, by satisfying a
demand not met by orthodoxy or by diversifying the conceptual
frameworks of medicine". A definition of CAM adopted by
the Cochrane Collaboration is "Complementary and alter-
native medicine (CAM) is a broad domain of healing resources
that encompasses all health systems, modalities and practices
and their accompanying theories and beliefs, other than those
intrinsic to the politically dominant health system of a particu-
lar society or culture in a given historical period. CAM includes
all such practices and ideas self-defined by their users as pre-
venting or treating illness or promoting health and well-being.
Boundaries within CAM and between the CAM domain and
that of the dominant system are not always sharp or fixed" [50]
Another definition which was coined by Eisenberg in
1993 in the USA and was then widely adopted is "medical
interventions not taught widely at U.S. schools or generally
available at U.S. hospitals" [8]. The World Health Organisa-
tion's definition of CAM is "all forms of health care which
usually lie outside the official health sector" [54]. The BMA
definition is that CAM covers "forms of treatments not widely
used by orthodox healthcare professions....skills of which are not
taught as part of the undergraduate curriculum of orthodox
medical and paramedical health care courses" [54]
Statistical analysis
Data was entered using Windows Excel 2000 and analysed
using SPSS 12 for Windows. The dependent variable for
statistical purposes was CAM use (yes/no). CAM use was
further sub-classified as CAM use only; CAM use in addi-
tion to use of conventional treatment. Prevalence esti-
mates including confidence intervals were calculated and
statistical testing of differences in prevalence between sub-
groups was carried out using the chi-square test.
We investigated non-response to participate in our inter-
views by using data from the original health surveys
undertaken by potential participants and compared those
who agreed to interview with those who did not with
respect to socio-demographic characteristics, general
health status (as measured by the Short-Form 36), and
lower limb joint pain and disability (as measured by the
WOMAC questionnaire), as well as use of prescribed pain
medication and home remedies for pain.
Results
Response and sample characteristics
Of the 427 patients invited, 138 participants responded
and all of them attended and completed the interviews
(response 32.3%). There were 39 (28%) in the age group
18–59 years, 51 (37%) between 60–69 years and 48
(35%) in the group 70 years or over; 55 participants were
male (40%) and 83 female (60%). Distribution by occu-
pational category was 68 (49%) professional or manage-
rial, 29 (21%) intermediate, and 41 (30%) routine and/or
manual. 37 participants reported pain in CPG grade I
(27%); 46 (33%) in grade II; 32 (23%) in grade III; and
23 (17%) in grade IV. 'Lower back' and 'knee' were the
most commonly reported areas of pain (52% and 48%
respectively). The majority (77%) reported pain in more
than one area.
Non-response
There were insignificant differences between respondents
and non-respondents in gender, age, health status or
severity of pain and disability. No differences appeared
either for health care use between the two groups (42% of
those who used at least one prescribed medication
responded, compared with 41% who did not; and 46% of
those who used at least one 'home remedy' responded,
compared with 39% who did not).
Use of CAM and conventional treatments
116 interview participants (84%, 95% CI = 78% – 90%)
said they had used at least one CAM treatment for pain in
the previous year; most (75/116, 65%) being current
users. The total number of CAM treatments ('episodes of
treatment use') reported by all CAM users was 321, which
represents an average of 2.8 episodes of CAM use in this
subgroup. Our study population represented users of con-
ventional services by virtue of all being GP consulters. Not
all of them, however, had been actually using conven-
tional treatment for their pain during the previous year,
even though they had seen their GP for their pain during
the same period. We therefore looked at the actual use of
conventional treatment. A total of 111 interview partici-Page 5 of 14
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one conventional treatment, mainly prescribed medica-
tion. 21 participants (15%) had used CAM treatments
only; 16 (12%) conventional treatments only; 95 (69%)
had used both CAM and conventional treatments, and 6
(4%) had not used CAM or conventional treatments.
Thus, most CAM users (95/116, 82%) and most conven-
tional treatment users (95/111, 86%) had used both dur-
ing the time period of recall.
Using the treatment list in the interviews led to an increase
in reporting of treatment use. The total number of occa-
sions on which any type of treatment (CAM and conven-
tional) had been mentioned as used at least once by
participants was 556, a mean of 4 treatments per person.
For 224 of these occasions, treatments were reported with
the aid of the list, representing an average increase of
reporting, after the list was shown, of 1.7 treatments per
person. The increased rate of reporting was higher for
CAM treatments (increased by 51%) compared with con-
ventional treatments (increased by 25.5%).
The prevalence of use of individual CAM treatments,
expressed as the proportion of all interviewees who
reported using a CAM treatment at least once, is shown in
table 2. In total, 32 of the 52 CAM treatments included on
the pre-specified lists had been used by at least one of the
study participants, and 28 further treatment names had
been used but not been included on the lists, 16 of which
were CAM (table 1). These 16 CAM treatments were each
used by either one or two participants, apart from exer-
cises which were mentioned as used by 19 participants.
Characteristics of treatment users
Table 3 compares CAM and conventional treatment use
by age, gender, socio-economic classification and Chronic
Pain Grade. There was an inverse association between age
and CAM use – older patients were significantly less likely
Table 2: Frequency of CAM treatment use, excluding 'other' CAM.
Treatment CAM users (Total n 116)
n %
Glucosamine 44 38
Fish oil 41 35
Massage Therapy 16 14
Copper bracelets 15 13
Magnets 15 13
Electrotherapy 12 10
Chondroitin sulphate 10 9
Osteopathic manipulation 10 9
Acupuncture 9 8
Aromatherapy 9 8
Evening primrose 7 6
Weight loss program 5 4
Devil's claw 5 4
Relaxation 5 4
Pilates 4 3
Prayer 4 3
Lifestyle program 3 3
Ginger 3 3
Acupressure 3 3
Reflexology 3 3
Soft tissue mobilisation 3 3
Yoga 3 3
Homeopathy 3 3
Chiropractic 2 2
Feverfew extract 1 1
Turmeric 1 1
Myofascial release 1 1
Therapeutic touch 1 1
Guided Imagery 1 1
Pet Therapy 1 1
Energy Healing 1 1
Hydrotherapy 1 1Page 6 of 14
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from women in their overall use of CAM, though women
were significantly more likely to use conventional treat-
ments, and hence the combined use of CAM and conven-
tional treatment was significantly higher in women.
CAM use was significantly different between socio-eco-
nomic classes; CAM use was higher in intermediate and
routine and manual occupations than in professional and
managerial occupations. A higher percentage of CAM use
was reported in those with CPG of III-IV compared to
those with CPG of I-II; the statistical test for trend was not
significant however. There was a significant trend toward
greater use of conventional treatments with increased
CPG category: 91% of those with CPG-IV had used con-
ventional treatments compare to 68% of patients with
CPG-I.
Reasons for using and stopping CAM treatments
Table 4 illustrates that the most commonly reported intro-
duction to using at least one CAM treatment was through
a recommendation from a friend or a relative (55/116,
47%). Most of the 116 CAM users (62, 53%) gave their
reason for using at least one of their CAM treatments as: 'I
like to try anything that may work'. Of the 321 episodes in
which CAM treatments were used, practitioners had been
involved in 128 (40%). Forty-one CAM users (41, 35%)
had stopped at least one of their CAM treatments. The
total number of episodes in which CAM treatments were
stopped was 144 (144/321, 45%). The reasons given for
stopping CAM treatments are shown in table 4.
Perceived helpfulness of CAM
A summary of helpfulness scores given for the most com-
monly used CAM and conventional treatments is shown
in figures 1a and 1b. Of the 14 most common CAM treat-
ments, osteopathy, relaxation, aromatherapy and evening
primrose had the highest median helpfulness scores i.e. 7
or above, whereas devil's claw and copper had the lowest
median scores i.e. zero (Figure 1).
Harm (negative scores on a (-1) to (-10) VAS) was
reported by eight users (8/116, 7%) from 7 CAM treat-
ments. Harm scores ranged from the highest of -10
reported for acupuncture (one user) to -4 reported for acu-
pupressure (one user), massage (2 users), electrotherapy
(one user) and chiropractic (one user) to -3 for devil's
claws (one user) and -2 for yoga (one user).
All five of the most commonly used conventional treat-
ments had median scores of 5 or above. However, not all
responses to use of conventional treatments were positive
(Figure 2).
Intention on future use of CAM
Most CAM users said they would use the particular CAM
treatment for pain in the future. Out of the 321 recorded
Table 3: Use of CAM and conventional treatments by socio-demographiccharacteristics and severity of pain.
n CAM treatment use n (%) Conventional treatment use n (%) Combined use n (%)
Yes No Yes No Yes No
All participants 138 116 (84) 22 (16) 111 (80) 27 (20) 95 (69) 43 (31)
Age groups
18–59 39 37 (95) 2 (5) 32 (82) 7 (18) 31 (79) 8 (21)
60–69 51 44 (86) 7 (12) 42 (82) 9 (18) 36 (71) 15 (29)
70+ 48 35 (73) 13 (27) 37 (77) 11 (23) 28 (58) 20 (42)
p = 0.005* p = 0.544 p = 0.033
Gender
Male 55 43 (78) 12 (22) 33 (60) 22 (40) 30 (55) 25 (45)
Female 83 73 (88) 10 (12) 78 (94) 5 (6) 65 (78) 18 (22)
p = 0.125 p < 0.001 p = 0.003
Socio-economic class
Professional or managerial 68 52 (76) 16 (24) 50 (74) 18 (26) 42 (62) 26 (38)
Intermediate 29 29 (100) 0 (0) 26 (90) 3 (10) 24 (83) 5 (17)
Routine or manual 41 35 (85) 6 (15) 35 (85) 6 (15) 29 (71) 12 (29)
p = 0.014 p = 0.119 p = 0.118
CPG
I 37 28 (76) 9 (24) 25 (68) 12 (32) 21 (57) 16 (43)
II 46 40 (87) 6 (13) 37 (80) 9 (20) 32 (70) 14 (30)
III 32 29 (91) 3 (9) 28 (88) 4 (12) 25 (78) 7 (22)
IV 23 19 (83) 4 (17) 21 (91) 2 (9) 16 (70) 7 (30)
p = 0.310 p = 0.013 p = 0.156
P-values were derived by chi square test (test for linear trend in the case of age group and CPG)Page 7 of 14
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277 (87%) of these again.
Discussion
Use of CAM and conventional treatment
Directly asking primary care consulters with chronic mus-
culoskeletal pain about how they treated their pain, with-
out indicating in the question that we were interested in
any particular class or group or type of treatment and not
asking the interviewees to distinguish between conven-
tional or CAM therapy, we found the prevalence of CAM
use high. More than four of every five patients interviewed
had used at least one CAM treatment, and more than two
thirds of CAM users were current users, representing more
than half of the study sample.
Using an open question alone, even though clearly
explaining that we were interested in every type of treat-
ment used, would still have provided us with incomplete
information, had we not used the list which appeared to
lead participants to mention more treatments. This could
be a simple issue of recall, but could also represent their
reluctance to admit to using certain treatments, especially
knowing that the interviewer was a doctor. Previous sur-
veys have found a similar effect [23,24,31]. The preva-
lence of CAM use, in one survey, increased from 56% to
85% when introducing a treatment list [33].
It has been shown that the larger the number of treat-
ments included on the list, the larger will be the estimates
of prevalence.[6,34]. It is possible that using such lists
could trigger incorrect memory or confuse participants
into thinking that they have used treatments that they
have not, because of similarities either in names or in
actual treatment technique (e.g. acupuncture and acupres-
sure). Such a possibility could inflate the prevalence with
inaccurate estimates. This has led some researchers to con-
fine their exploratory work to a small number of treat-
ments in order to obtain precise information [6]. We were
aware of this issue and the trade-off between obtaining
accurate information on a small number of treatments
and exploring all treatments that were being used for pain.
Because we used face-to-face interviews, we used the
opportunity to deal with any possible confusion and clar-
ify that the participant had actually used the treatment.
Such opportunity would not have been available if other
methods had been used e.g. postal survey. Secondly, we
asked a number of detailed questions about each treat-
ment reported, and this would have reduced the chance
that the participant might have mentioned the treatment
by mistake.
The extent of the increase in reporting treatment use in
conjunction with the list was twice as high with CAM as
with conventional treatments (164/321, 51% vs 60/235,
25.5%). A possible explanation is that participants might
have been less likely to volunteer, to a doctor, information
related to CAM compared with conventional treatments,
an observation made in previous surveys [9,24,35]. This
would correlate with the comments of many participants
that they did not realise that we were also interested in
these (CAM) treatments. We were not able to find a simi-
Table 4: Reasons for using and stopping CAM treatments.
Ways participants introduced to CAM n (%) Reasons for using CAM n (%) Reasons for stopping CAM n (%)
Recommended by a friend or a relative. 55 (47) I like to try anything that may work 62 (53) I finished the treatment course 39 (27)
Prescribed, or referred to it, by a health 
professional
35 (30) I was referred to it or it was prescribed for me 29 (25) I don't think I need it anymore 13 (9)
Media (TV, radio, newspapers, Internet) 27 (23) I find that it helps me in general not just for pain 23 (20) Cannot afford it 6 (4)
Literature 10 (9) I believe in it 22 (19) It caused me problems or side effects 6 (4)
Practice it/involved with it 10 (9) Other treatment caused me problems or side effects 2 (2) I heard of a bad experience with it 1
Not available where I live 0
My doctor advised me against it 0
Other ways* 22 (19) Other reasons* 19 (16) Other reasons* 79 (55)
Found it in a shop Brought in by a relative Didn't help 40
Local advertisement Compatible with birth sign Only use it when I need it 31
Previous experience Suggestion by others Not practical
Family experience Persuaded by evidence Caused more pain
Experience at vet use Natural product Staining
Workshop Carried on, don't know
Health farm Family experience
Own initiative Has no side effects
Practitioner is a friend Previous experience
The gym Heard its good
Social class Recommended in a magazine
Thought it may work
Total 116 Total 116 Total 144
*These other ways/reasons were not included in our lists and were offered freely by participants. Items are listed in a descending order according 
to how commonly they were mentioned.Page 8 of 14
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ing CAM and conventional treatments among the
published surveys in the literature.
We were not aware of published surveys that specifically
targeted primary care patients in the UK to explore their
CAM use for musculoskeletal pain. It is difficult therefore
to compare our findings with those from previous surveys
in the UK, many of which either targeted patients attend-
ing hospital clinics and who had known diagnoses e.g.
rheumatoid arthritis [14,16,17,35,36], fibromyalgia
[15,37], multiple sclerosis [38] or post-spinal cord injury
[39] or targeted individuals in the community [10,11] suf-
fering from chronic pain in general and not specifically
musculoskeletal pain. Surveys that looked at CAM use in
primary care in the UK mainly explored access to CAM
and GPs' use and attitude towards it. It was found in a
number of these surveys that between 39% and 83% of
participating GPs were 'active' with respect to CAM, i.e.
practising it, referring for it or endorsing it to their patients
[4,5,19,20,22,23]. This could be one possible reason for
the high rate of use of these treatments among their
patients. We did not ask our participants whether some
CAM treatments were practised by conventional health
professionals. We know, however, that a third of CAM
users in our study said that they came to use CAM because
they were referred to it, or it was recommended, by a
health professional. For a quarter of CAM users in our
study, that was their main reason for using CAM treat-
ments. This obviously refers only to CAM use for chronic
musculoskeletal pain and does not include its use for
other reasons. This could indicate high 'activity' in rela-
tion to CAM in the general practices in the area where we
conducted our study, which could explain high CAM use
among individuals like our sample of primary care
patients. It would be interesting to explore any direct asso-
ciation between GPs activity with regard to CAM and its
use among their patients.
In the USA, surveys have explored CAM use among pri-
mary care patients [40-42]. However, it was general use of
CAM that was explored rather than use linked to a specific
condition or symptom. In one survey [40], it was found
that 21% of patients, interviewed while visiting their pri-
mary care doctor, had used CAM treatment for the medi-
cal problem linked with that GP visit. It is difficult to
apply findings related to family medical practice in the
USA with primary care in the UK because of the variations
in structure, profile and activity.
Surveys among pain sufferers found the prevalence of
CAM use ranging from 16% up to 100% in the UK
[11,12,14-17] and the USA [10,35-39,43]. The variation
in the prevalence figures is likely to reflect variation in sur-
vey methodologies. The majority of these surveys, how-
ever, showed the prevalence of CAM use to be consistently
higher among pain sufferers compared with other
patients.
The two main characteristics that our participants have,
namely that they are actively using primary healthcare and
that they suffer from chronic musculoskeletal pain, would
make them, according to these previous surveys, the more
likely users of CAM. This puts the high prevalence figure
observed in our study into perspective.
Our study participants were, by selection, users of conven-
tional healthcare, most having made more than two visits
to their general practitioner in the previous year. We
found that most of this study population were actually
using conventional treatment in combination with CAM.
This suggests that patients whom GPs saw most frequently
for musculoskeletal pain were more likely than not to be
using CAM treatments as well. This is consistent with the
extensive use of CAM and conventional healthcare serv-
ices by patients with chronic pain observed in previous
surveys [11,44].
The high rate of combined use of CAM and conventional
treatments could reflect high unmet needs. Surveys have
shown that regardless of whether a chronic illness was
reported, CAM users tend to report poorer health com-
Boxplot summary of perceived helpfulness scores on the VAS f r the ost commonly used conv ntional treatmentsFigure 2
Boxplot summary of perceived helpfulness scores on the 
VAS for the most commonly used conventional treatments. 
Values represented are number of users and 5-number sum-
mary (median, 25th and 75th percentiles and range) and out-
lier observations (data that lie outside the interval: median ± 
1.5× mid-spread).Page 9 of 14
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[46] it was found that use of CAM was more than twice as
common among high users as among low users of medi-
cal services in general suggesting that high combined use
represents a characteristic of the individuals and is unre-
lated to their health status or needs.
The high grade of severity of reported pain among our par-
ticipants would probably be expected with our partici-
pants being active users of the health service because of
their pain. The positive association between the frequency
of GP visits and pain severity has been identified in previ-
ous surveys [11,47]. 60% of our participants had visited
their GP at least twice during the previous year for muscu-
loskeletal pain and 80% were using some form of conven-
tional treatment, mainly prescribed medications. It
appears, therefore, that the majority of our patients with
chronic musculoskeletal pain who use both CAM and
conventional treatments and are visiting their GP (for
whatever reason) are still symptomatic and it is possible
that this is one reason for their use of both types of treat-
ment. This is important because it increases the relevance
of the high use of CAM treatments by chronic muscu-
loskeletal pain patients. It seems to tally with the common
perception among GPs of the lack of effective treatments
for such symptoms. This would lead some patients at least
to try anything that might help with their pain.
It is important to note that by targeting chronic muscu-
loskeletal pain sufferers who are using primary care serv-
ices, a group of patients with the same pain and who are
not using primary care services were not reached by this
study. This is a potentially important group of patients,
some of whom might be exclusively using CAM for pain.
We cannot comment in this study on the use of CAM
among such group and our findings remain only applica-
ble to primary care consulters.
CAM definition
The availability of a single agreed epidemiological defini-
tion is important for surveys if the results are to be com-
prehensible and comparable. The use of varied definitions
for CAM, as was highlighted earlier, has its effect on
research in this field. That effect is evident from the type
of research questions used in these surveys and the wide
range of prevalence figures for use of CAM. Considering
the types of 'treatments' which fall under the umbrella of
CAM, it seems that for a part of them at least local availa-
bility and recognition is important to correctly estimate
the prevalence of their use. On the other hand, this local
approach needs to be balanced by the need to accurately
compare findings of various surveys.
We therefore have used a local consensus on what is con-
sidered as CAM or conventional treatment and we also
present our findings for individual treatments to allow for
differing definitions to be applied and for accurate com-
parison to be made.
Socio-demographic characteristics of treatment users
The typical socio-demographic characteristics of the
majority of CAM users in our study did not echo those
from the majority of studies in which CAM users were
found more likely to be women [11,48] from higher
social class groupings. [9,11,44,46,48] There are, how-
ever, studies which did not find a link between higher
CAM use and higher income [40] or any significant differ-
ence by gender among CAM users [5,35,48].
The reason for the contrast between our results and other
studies' might lie in regional variations in CAM use
[46,49] or might represent patterns specific to sufferers of
chronic musculoskeletal pain.
It has been suggested that the observed regional variation
in CAM use more likely to reflect variation in access and
availability than regional differences in public attitude
and interest [50]. Access to these treatments can be
severely restricted, with 90% of CAM provided in the pri-
vate sector [44], leading to the suggestion that its use is
related to the affluence of the area [4]. Surveys have
shown that CAM use in the south west of England, for
example, was higher than the national average (16% vs
10%) [22].
Geographical variation in the availability and provision of
CAM has been suggested as another possible explanation
for variation in use [4,11,50]. One factor that was shown
to influence CAM availability is the nature of local con-
ventional healthcare services and primary care in particu-
lar (i.e. practices' attitude towards CAM and its provision;
GP's special interest in CAM or antipathy towards it) [22].
GP endorsement of these treatments varied between areas
(38% in Liverpool area vs 54% in the south west of Eng-
land) [22,23] as well as their active involvement i.e. prac-
ticing CAM [4,22]. Variation in demand could also
influence availability of CAM. It has been shown that the
prevalence of chronic pain, one of the most common
health problems for which CAM is used, varied widely
across geographical areas. [51]
It is interesting to attempt to explain our finding of the
higher use of CAM and conventional treatments com-
bined among women compared with men. It has been
shown in one survey at least, that women were more likely
than men to report chronic pain with no difference
between genders in the reported severity of pain.[47,52]
which could arguably offer an explanation. Women were
also more likely to report high expressed needs than men
[47]. In another study, where use of healthcare servicesPage 10 of 14
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used prescription and non-prescription medications,
alternative therapist and alternative medication [11]. This
could suggest that the high use among women, compared
with men, of both conventional and unconventional
medicine for pain, is related to their higher expressed
needs and not to the severity of the reported pain.
Perceived helpfulness from using CAM
Attempts to assess this have been made in past surveys
from information mainly based on doctors' reports of
their patients' benefit from using CAM [23,48,19,53].
However doctors' knowledge of their patients' use of CAM
is often very limited [9,24] and the views of doctors and
patients on the usefulness of CAM may differ [40].
There has been much recent debate about the lack of avail-
able evidence regarding the efficacy of CAM treatments.
CAM treatments in our study were generally found to be
helpful by participants, echoing previous findings from
one systematic review [24]. This might represent what is
called as the effectiveness gap [56], although in a reversed
way. The effectiveness gap is said to exist when a treatment
is shown to have an effect based on its pharmacological
action but shows a smaller effectiveness in clinical prac-
tice. Here, the gap seems to exist when treatments (such as
some CAM treatments) are perceived to be helpful by
users when no evidence for their effect exists.
Although the number of participants who reported expe-
riencing harm in the form of worsening pain symptoms
following the use of some CAM treatments was small and
although these data do not represent an objective measure
of effectiveness, one conclusion is that, although benefi-
cial effects on pain from each CAM treatment are com-
monly reported, many users do not perceive CAM to be
automatically beneficial, and a number of them (substan-
tial if extrapolated nationally) considered themselves to
have experienced harmful effects.
The range of scores for perceived helpfulness from the
commonly used conventional treatments was wider than
for CAM treatments, and there were higher harm scores.
The latter might be balanced or off-set by evidence of
effectiveness the likes of which is lacking for many CAM
treatments. Interestingly, some of the favourable CAM
treatments, such as chondroitin sulphate and osteopathy,
had higher average ratings for perceived helpfulness than
paracetamol, ibuprofen and co-codamol. The differences
in the numbers of users, however, make accurate compar-
ison difficult beyond mathematical extrapolation. This
issue merits further investigation.
An important finding in our study was the instances
where participants reported harm attributed to the use of
treatments. The eight instances of harm attributed to the
use of seven CAM treatments represent a small percentage
of the total number of instances on which CAM treat-
ments were used. These seven CAM treatments had been
used 52 times in this study's population.
Some observations could be made on these harm reports.
Firstly, these harm scores were reported for some treat-
ments that also received high perceived helpfulness scores
from other users. Electrotherapy received nine positive
scores (+2 to +8), massage received 14 positive scores (+1
to +10) and acupuncture received 5 positive scores (+3 to
+9). Secondly, although the question was about perceived
helpfulness in relation to pain, we believe that reported
negative scores might not have always meant "worsening
of pain following using the treatment" but might also
meant other adverse effects which may not be related to
pain. We did not expand on the nature of the harmful
effect that was reported and this information was col-
lected as a score on the negative arm of (-10) to (+10)
VAS. Thirdly we do not know whether these effects were
reliably caused by these treatments. The answers were
purely subjective.
It is interesting to compare the number of these reported
harmful incidents with the number of participants who
said that they have stopped CAM because it caused them
problems or side effects. These reasons for stopping were
given on fewer occasions of CAM use (six) than reported
harmful events (eight) and not all these cases are the
same. This could either reflect the unreliability of the
assessment made by the participants, or that some of
them did report harm which was not of a type or severity
that had made them stop the treatment. Finally, it seems
that reporting harm was more likely to be related to prac-
titioner dependent treatments, although the number of
instances was too small to validate this conclusion.
Although the number of reported perceived harm
instances is small, they are nevertheless important. They
highlight the fact that these treatments are not universally
experienced or perceived as harmless. They are also
important in the debate about the safety of CAM and its
integration within the mainstream health services.
Harmful events attributed to CAM use have been reported
previously. 38% of GPs in one survey reported adverse
effects related to CAM use by their patients [22]. In
another survey, 21% of responding GPs reported similar
harmful effects [23]. A survey in Australia found that 25%
of users of naturopathy reported effects [55]. The adverse
events reported in the surveys studied in a systematic
review of the use of CAM in rheumatology were low [26].
In addition to users' views and perceptions on harm, doc-
tors, on the other hand, have a different view of the harmPage 11 of 14
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62% of the participating physicians suggested that CAM
use prevents patients from getting proper treatment [21].
The issue of perceived helpfulness is important, with
implications for safety, integration and future research.
With the increasing use of CAM and the increasing
amount of anecdotal evidence for its helpfulness, or oth-
erwise, by users, some are suggesting that there should be
room for debate as to who decides what is and what is not
effective and on what basis, at least in the NHS [12].
Future intention on using CAM
We could not find published surveys in the UK that
addressed this issue, although it has been reported in
American surveys [48] where strong intentions to use
CAM again in the future were identified. Future use of
CAM may be influenced by perceived helpfulness [48]. In
our study, there was a contrast between the intention on
future use of conventional treatments, which most partic-
ipants felt would be strongly influenced by doctors'
advice, and future use of CAM which appears to be more
dependent on a wish to try anything that might help.
Response and generalisability
A limitation to the study was the higher than anticipated
reluctance to be interviewed, which meant that we had a
final study population of 138 as opposed to the 180 pre-
specified in the sample size pre-requisite. We had also
underestimated the amount of CAM use. Revisiting the
power calculation post hoc and taking a 20% difference in
CAM use based on a greater base value of 80% CAM use
in the study population, meant that given a sample size of
138 we had 79% power of detecting this difference if it
existed i.e. there was little loss in power compared to the
prior calculation.
We took advantage of the fact that our patients had com-
pleted earlier postal surveys to compare responders and
non-responders with respect to gender, age, pain and
health status scores and health care use in general, as well
as use of specific 'home remedies' (e.g. cod liver oil) which
had been enquired about in the postal questionnaires.
Differences were small and it is unlikely that those inter-
viewed represent an unusual sample of our target popula-
tion with respect to their general experience of pain and
willingness to use a variety of treatments. Furthermore
CAM was not mentioned or referred to during our study,
and so responders are unlikely to represent a group specif-
ically interested in this topic.
Generalising our study findings to the wider population
of all patients with chronic musculoskeletal pain who are
using primary healthcare services in the UK would require
caution. CAM use varies between different parts of the
country [23,19], and this may influence use among con-
sulters also. This variation might explain why the use of
some individual CAM treatments, such as Homeopathy,
was lower among our participants compared with other
surveys' [6]. However it seems unlikely that the broad pat-
terns identified here would differ substantially in other
primary care settings.
Conclusion
We have estimated the prevalence of CAM use among
musculoskeletal pain consulters in primary care in the
UK, by directly asking a sample of such patients about all
the methods which they used to alleviate their pain. The
high rate of CAM use and wide range of experience of ben-
efit and harm strengthen the argument for research to
quantify benefit and assess safety of this type of treatment.
The fact that the majority of CAM users in our study
remained active users of conventional medicine and that
their use of CAM was related to the persistence of their
pain further highlights the importance of the research on
the optimal management of pain in primary care.
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